NCT00099905View on ClinicalTrials.gov

A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

639

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY